The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-cyclohexyl-10-methyl-3-p-tolylpyrimido[4,5-b]quinoline-4,5(3H,10H)-dione ID: ALA4762375
PubChem CID: 85090333
Max Phase: Preclinical
Molecular Formula: C25H25N3O2
Molecular Weight: 399.49
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(-n2c(C3CCCCC3)nc3c(c(=O)c4ccccc4n3C)c2=O)cc1
Standard InChI: InChI=1S/C25H25N3O2/c1-16-12-14-18(15-13-16)28-23(17-8-4-3-5-9-17)26-24-21(25(28)30)22(29)19-10-6-7-11-20(19)27(24)2/h6-7,10-15,17H,3-5,8-9H2,1-2H3
Standard InChI Key: AYWKCNXUVSVHMI-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
9.2372 -2.6658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2360 -3.4928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9507 -3.9056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9488 -2.2531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6640 -2.6621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6648 -3.4887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3798 -3.8995 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3742 -2.2482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0898 -2.6552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0935 -3.4846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8123 -3.8943 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5281 -3.4758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5205 -2.6434 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8010 -2.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3698 -1.4234 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.7939 -1.4126 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2254 -2.2252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9439 -2.6325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6537 -2.2140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6462 -1.3884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9231 -0.9831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2163 -1.4039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2408 -3.8820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2448 -4.7077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9579 -5.1148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6717 -4.7007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6675 -3.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9499 -3.4634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3560 -0.9684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3819 -4.7243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 1 0
9 8 1 0
8 5 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 9 1 0
8 15 2 0
14 16 2 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
13 17 1 0
23 24 1 0
23 28 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
12 23 1 0
20 29 1 0
7 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 399.49Molecular Weight (Monoisotopic): 399.1947AlogP: 4.59#Rotatable Bonds: 2Polar Surface Area: 56.89Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.42CX LogD: 5.42Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.46Np Likeness Score: -0.80
References 1. Luderman KD,Jain P,Benjamin Free R,Conroy JL,Aubé J,Sibley DR,Frankowski KJ. (2021) Development of pyrimidone D1 dopamine receptor positive allosteric modulators., 31 [PMID:33221389 ] [10.1016/j.bmcl.2020.127696 ]